{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:49:13Z","timestamp":1771933753674,"version":"3.50.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T00:00:00Z","timestamp":1334275200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0035427","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T17:01:19Z","timestamp":1334336479000},"page":"e35427","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Fenofibrate Reduces Mortality and Precludes Neurological Deficits in Survivors in Murine Model of Japanese Encephalitis Viral Infection"],"prefix":"10.1371","volume":"7","author":[{"given":"Neha","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanhaiya Lal","family":"Kumawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anirban","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayalakshmi","family":"Ravindranath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,4,13]]},"reference":[{"key":"ref1","first-page":"1525","article-title":"Japanese encephalitis\u2013an encephalomyelitis.","volume":"28","author":"R Kumar","year":"1991","journal-title":"Indian Pediatr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1099\/0022-1317-83-8-1897","article-title":"Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs.","volume":"83","author":"CJ Chen","year":"2002","journal-title":"J Gen Virol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1371\/journal.pntd.0000437","article-title":"Japanese encephalitis-a pathological and clinical perspective.","volume":"3","author":"D Ghosh","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref4","first-page":"9","article-title":"Clinical sequelae of Japanese encephalitis in children.","volume":"97","author":"R Kumar","year":"1993","journal-title":"Indian J Med Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF00309631","article-title":"Japanese encephalitis virus antigen in the human brain and its topographic distribution.","volume":"89","author":"A Desai","year":"1995","journal-title":"Acta Neuropathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/glia.20474","article-title":"Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis.","volume":"55","author":"A Ghoshal","year":"2007","journal-title":"Glia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1471-4159.2008.05238.x","article-title":"Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis.","volume":"105","author":"MK Mishra","year":"2008","journal-title":"J Neurochem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1086\/423328","article-title":"Proinflammatory cytokines and chemokines in humans with Japanese encephalitis.","volume":"190","author":"PM Winter","year":"2004","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms.","volume":"8","author":"ML Block","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.plefa.2003.08.005","article-title":"Involvement of eicosanoids in the hypothermic response to lipopolysaccharide during endotoxemia in rats.","volume":"70","author":"AN Azab","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology.","volume":"294","author":"CD Funk","year":"2001","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.abb.2007.02.027","article-title":"Catalytic characterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytes.","volume":"461","author":"A Kalsotra","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity.","volume":"2","author":"RA Daynes","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"538141","DOI":"10.1155\/2008\/538141","article-title":"Peroxisome proliferator-activated receptors: \u201ckey\u201d regulators of neuroinflammation after traumatic brain injury.","volume":"2008","author":"PF Stahel","year":"2008","journal-title":"PPAR Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST0341341","article-title":"PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.","volume":"34","author":"R Bordet","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1155\/S1110724304308065","article-title":"Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control.","volume":"2004","author":"J Youssef","year":"2004","journal-title":"J Biomed Biotechnol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1460-9568.2011.07637.x","article-title":"Peroxisome proliferator-activated receptor-alpha agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function.","volume":"33","author":"E Gray","year":"2011","journal-title":"Eur J Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1523\/JNEUROSCI.23-15-06264.2003","article-title":"Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.","volume":"23","author":"D Deplanque","year":"2003","journal-title":"J Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2174\/138161209787315675","article-title":"Pleiotropic effects of fenofibrate.","volume":"15","author":"V Tsimihodimos","year":"2009","journal-title":"Curr Pharm Des"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/neu.2006.0216","article-title":"Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury.","volume":"24","author":"XR Chen","year":"2007","journal-title":"J Neurotrauma"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcp.2011.03.025","article-title":"Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation.","volume":"82","author":"N Sehgal","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"72","author":"MM Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jneuroim.2003.10.033","article-title":"Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis.","volume":"146","author":"SS Soldan","year":"2004","journal-title":"J Neuroimmunol"},{"key":"ref24","first-page":"532","article-title":"A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples.","volume":"15","author":"P Chomczynski","year":"1993","journal-title":"Biotechniques"},{"issue":"Pt 7","key":"ref25","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1099\/0022-1317-80-7-1665","article-title":"Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth.","volume":"80","author":"S Vrati","year":"1999","journal-title":"J Gen Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.micinf.2009.09.013","article-title":"Highly permissive infection of microglial cells by Japanese encephalitis virus: a possible role as a viral reservoir.","volume":"12","author":"T Thongtan","year":"2010","journal-title":"Microbes Infect"},{"key":"ref27","article-title":"Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors.","author":"A Peyrl","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/01.sla.0000250409.51289.ca","article-title":"Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate.","volume":"245","author":"MG Cree","year":"2007","journal-title":"Ann Surg"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00431-005-0009-8","article-title":"Treatment of hyperlipidemia associated with Niemann-Pick disease type B by fenofibrate.","volume":"165","author":"JH Choi","year":"2006","journal-title":"Eur J Pediatr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00228-009-0723-7","article-title":"Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.","volume":"65","author":"J Wu","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/08860220701573640","article-title":"Acute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis.","volume":"29","author":"M Tahmaz","year":"2007","journal-title":"Ren Fail"},{"key":"ref32","first-page":"573","article-title":"[Rhabdomyolysis induced by fenofibrate monotherapy].","volume":"27","author":"F Archambeaud-Mouveroux","year":"2006","journal-title":"Rev Med Interne"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.2337\/diacare.26.8.2482","article-title":"Fenofibrate monotherapy induced rhabdomyolysis.","volume":"26","author":"BJ Barker","year":"2003","journal-title":"Diabetes Care"},{"key":"ref34","article-title":"Rhabdomyolysis-induced acute renal failure following fenofibrate therapy: a case report and literature review.","volume":"2010","author":"D Ramazan","year":"2010","journal-title":"Case Reports in Medicine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00467-009-1223-9","article-title":"Rhabdomyolysis: a review, with emphasis on the pediatric population.","volume":"25","author":"EF Elsayed","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs.","volume":"53","author":"J Berger","year":"2002","journal-title":"Annu Rev Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.pharmtox.40.1.491","article-title":"Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators.","volume":"40","author":"JC Corton","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2009.03.008","article-title":"Peroxisome proliferator-activated receptor-alpha (PPARalpha): at the crossroads of obesity, diabetes and cardiovascular disease.","volume":"205","author":"JC Fruchart","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2007.04.080","article-title":"Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.","volume":"124","author":"KK Koh","year":"2008","journal-title":"Int J Cardiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/phrs.2001.0871","article-title":"PPARS, metabolic disease and atherosclerosis.","volume":"44","author":"JC Fruchart","year":"2001","journal-title":"Pharmacol Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2010.08.075","article-title":"Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels.","volume":"1359","author":"G Wang","year":"2010","journal-title":"Brain Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0925-4439(95)00084-4","article-title":"Hydrogen peroxide metabolism during peroxisome proliferation by fenofibrate.","volume":"1272","author":"SL Arnaiz","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-9072-3_22","article-title":"A paradigm for gene regulation: inflammation, NF-kappaB and PPAR.","volume":"544","author":"W Vanden Berghe","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"36703","DOI":"10.1074\/jbc.M004045200","article-title":"Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators.","volume":"275","author":"P Delerive","year":"2000","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/384039a0","article-title":"The PPARalpha-leukotriene B4 pathway to inflammation control.","volume":"384","author":"PR Devchand","year":"1996","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pharmthera.2006.03.008","article-title":"Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism.","volume":"112","author":"A Kalsotra","year":"2006","journal-title":"Pharmacol Ther"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1089\/neu.2008.0542","article-title":"CYP4Fs expression in rat brain correlates with changes in LTB4 levels after traumatic brain injury.","volume":"25","author":"Y Wang","year":"2008","journal-title":"J Neurotrauma"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.18.2.269","article-title":"Antiviral activity of antilipidemic compounds on herpes simplex virus type 1.","volume":"18","author":"JK Mehl","year":"1980","journal-title":"Antimicroblal agents and chemotherapy"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00126334-200209010-00001","article-title":"Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects.","volume":"31","author":"PR Skolnik","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11908-010-0098-z","article-title":"New vaccines for Japanese encephalitis.","volume":"12","author":"SB Halstead","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QCO.0b013e32833c1d01","article-title":"Japanese encephalitis: update on vaccines and vaccine recommendations.","volume":"23","author":"A Wilder-Smith","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbrc.2010.04.133","article-title":"Design and evaluation of a multi-epitope peptide against Japanese encephalitis virus infection in BALB\/c mice.","volume":"396","author":"JC Wei","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11908-009-0006-6","article-title":"Japanese encephalitis: new vaccines.","volume":"11","author":"ME Wilson","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14787210.4.2.313","article-title":"Japanese encephalitis: development of new candidate vaccines.","volume":"4","author":"K Bharati","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13550280390218454","article-title":"Development of a recombinant vaccine against Japanese encephalitis.","volume":"9","author":"R Kaur","year":"2003","journal-title":"J Neurovirol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0035427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T04:45:56Z","timestamp":1561610756000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0035427"}},"subtitle":[],"editor":[{"given":"Nancy M.","family":"Sawtell","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,13]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0035427","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,13]]}}}